| Bioactivity | APTSTAT3-9R, scrambled (APTscr-9R) is a control peptide that forms a structure similar to that of APTSTAT3-9R but possesses a scrambled sequence in the target-binding region[1]. |
| Name | APTSTAT3-9R, scrambled |
| Sequence | His-Ala-Ser-Asp-Arg-Asn-Gly-Ser-Trp-Thr-Trp-Glu-Asn-Gly-Lys-Trp-Thr-Trp-Lys-Gly-Leu-His-Glu-Gln-Ser-Asp-Gly-Gly-Gly-Gly-Ser-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg |
| Shortening | HASDRNGSWTWENGKWTWKGLHEQSDGGGGSRRRRRRRRR |
| Formula | C202H315N83O58 |
| Molar Mass | 4834.18 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tae Woo Kim, et al. Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma. Mol Ther Oncolytics. 2022 Jun 6:26:1-14. |
APTSTAT3-9R, scrambled
CAS: F: C202H315N83O58 W: 4834.18
APTSTAT3-9R, scrambled (APTscr-9R) is a control peptide that forms a structure similar to that of APTSTAT3-9R but posses
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.